Hypolipidaemic effects of fenofibrate are not altered by mildronate-mediated normalization of carnitine concentration in rat liver

Biochimie

Volumn 80, Issue 11, 1998, Pages 943-948

  Tsoko, Marcelline ^a   Beauseigneur, Frédéric ^a   Gresti, Joseph ^a   Demarquoy, Jean ^a   Clouet, Pierre ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Blood lipids; Fatty acid oxidation; Fenofibrate; L carnitine

Indexed keywords

ANTILIPEMIC AGENT; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; CHOLESTEROL; ENZYME INHIBITOR; FENOFIBRATE; KETONE BODY; MILDRONATE; MITOCHONDRIAL ENZYME; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FATTY ACID OXIDATION; GASTROCNEMIUS MUSCLE; HEART; LIPID LIVER LEVEL; LIVER LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOSPHOLIPID BLOOD LEVEL; RAT; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA;

EID: 0032299933     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(00)88891-4     Document Type: Article

References (28)

1. [1] Lindstedt G., Hydroxylation of gamma-butyrobetaine to carnitine in rat liver, Biochem. J. 6 (1967) 1271-1282.
2. [2] Fritz I.B., The metabolic consequences of the effects of carnitine on long-chain fatty acid oxidation, in: Gran F.C. (Ed.), Cellular compartmentalization and control of fatty acid metabolism, Academic Press, New-York, 1968, pp. 39-63.
3. [3] McGarry J.D., Meier J.M., Foster D.W., The effects of starvation and refeeding on carbohydrate and lipid metabolism in vivo and in the perfused rat liver. The relationship between fatty acid oxidation and esterification in the regulation of ketogenesis, J. Biol. Chem. 248 (1973) 270-278.
4. [4] Mc Carry J.D., Robles-Valdes C., Foster D.W., Role of carnitine in hepatic ketogenesis, Proc. Natl. Acad. Sci. USA 72 (1975) 4385-4388.
5. [5] Maebashi M., Kawamura N., Sato M., Imamura A., Yoshinaga K., Suzuki M., Urinary excretion of carnitine in patients with hyperthyroidism and hypothyroidism. Augmentation by thyroid hormone, Metabolism 26 (1977) 351-355.
6. [6] Clouet P., Henninger C., Niot I., Bézard J., Carnitine and malonyl-CoA contents in several tissues of fenofibrate-treated obese and lean Zucker rats, Biochem. Pharmacol. (Life Sci. Adv.) 9 (1990) 283-287.
7. [7] Mannaerts G.P., Thomas J., Debeer L.J., McGarry J.D., Foster D.W., Hepatic fatty acid oxidation and ketogenesis after clofibrate treatment, Biochim. Biophys. Acta 529 (1978) 201-211.
8. [8] DeGennes J.L., Truffer J., Advantages of hypolipidemic effects of procetofen over clofibrate therapy, Adv. Exp. Biol. 109 (1978) 374-379.
9. [9] Oliver M.F., Further observations of the effects of atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levels, Atheroscler. Res. 3 (1963) 427-444.
10. [10] Simkhovich B., Shutenko Z., Meirena D., Khagi K., Mezapuke R., Molodchina T., Kalvins I., Lukevics E., 3-(2,2,2-trimethylhydrazinium) propionate (TPH). A novel γ-butyrobetaine hydroxylase inhibitor with cardioprotective properties, Biochem. Pharmacol. 37 (1988) 195-202.
11. [11] Clouet P., Niot I., Bézard J., Pathway of α-linolenic acid through the mitochondrial outer membrane in the rat liver and influence on the rate of oxidation, Biochem. J. 263 (1989) 867-873.
12. [12] McGarry J.D., Foster D.W., An improved and simplified radioisotopic assay for the determination of free and esterified carnitine, J. Lipid Res. 17 (1976) 277-281.
13. [13] Weissbach H., Smith T.E., Daly J.W, Witkop B., Udenfriend, S., A rapid spectrophometric assay of monoamine oxidase based on the rate of disappearance of kynuramine, J. Biol. Chem. 235 (1960) 1160-1163.
14. [14] Bremer J., The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA, Biochim. Biophys. Acta 665 (1981) 628-631.
15. [15] Bronfman M., Inestrosa N.C., Leighton F., Fatty acid oxidation by human liver peroxisomes, Biochem. Biophys. Res. Commun. 88 (1979) 1030-1036.
16. [16] Folch J., Lees M., Sloane-Stanley G.H., A simple method for the isolation and purification of total lipids from animal tissues, J. Biol. Chem. 226 (1957) 497-509.
17. [17] Niot I., Gresti J., Boichot J., Semporé G., Durand G., Bézard J1, Clouet P., Effect of dietary n-3 and n-6 polyunsaturated fatty acids on lipid-metabolizing enzymes in obese rat liver, Lipids 29 (1994) 481-489.
18. [18] Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C., Measurement of protein using bicinchoninic acid, Anal. Biochem. 150 (1985) 76-85.
19. [19] Wittels B., Bressler R., Biochemical lesion of diphtheria toxin in the heart, J. Clin. Invest. 43 (1964) 630-637.
20. [20] Triscari J., Greenwood M., Sullivan A., Oxidation and ketogenesis in hepatocytes of lean and obese Zucker rats, Metab. Clin. Exp. 31 (1982) 223-228.
21. [21] McGarry J.D., Mannaerts G.P., Foster D.W., A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis, J. Clin. Invest. 60 (1977) 265-270.
22. [22] Mannaerts G.P., Debeer L.J., Thomas J., DeSchepper P.J., Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats, J. Biol. Chem. 254 (1979) 4585-4595.
23. [23] Hawkins J.M., Jones W.E., Bonner F.W., Gibson G.G., The effects of peroxisome proliferators on microsomal and mitochondrial activities in the liver and kidney, Drug Metab. Rev. 18 (1987) 441-515.
24. [24] Lalwani N.D., Reddy M.K., Qureshi S.A., Sirtori C.R., Abiko Y., Reddy J.K., Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver, Human Toxicol. 2 (1983) 27-48.
25. [25] Blane G.F., Pinaroli F., Fénofibrate : études de toxicologie animale en rapport avec les effets secondaires chez les malades, Nouv. Presse Med. 9 (1980) 3737-3746.
26. [26] Henninger C., Clouet P., CaoDanh H., Pascal M., Bézard J., Effects of fenofibrate treatment on fatty acid oxidation in liver mitochondria of obese Zucker rats, Biochem. Pharmacol. 36 (1987) 3231-3236.
27. [27] Kurup C.K.R., Aithal H.N., Ramasarma T., Increase in hepatic mitochondria on administration of ethyl-δ-p-chlorophenoxyisobutyrate to the rat, Biochem. J. 116 (1970) 773-779.
28. [28] Lazarow P., De Duve C., A fatty acyl-CoA oxidizing system in rat liver peroxisomes, enhancement by clofibrate, a hypolipidemic drug, Proc. Natl. Acad. Sci. USA 73 (1976) 2043-204.